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Spontaneous Angiographic Conversion of Intracranial Dural
Arteriovenous Shunt
Long-Term Follow-Up in Nontreated Patients
Dong Joon Kim, MD; Karel terBrugge, MD, FRCPC; Timo Krings, MD, PhD, FRCPC;
Robert Willinsky, MD, FRCPC; Christopher Wallace, MD, MSc, FRCSC
Background and Purpose—Dural arteriovenous shunt (DAVS) is a disease in which abnormal arteriovenous communi-
cations develop within the dura. Some case series have suggested DAVS may evolve over time, but the natural history
is poorly understood. In this study, we aimed to define the incidence and clinical characteristics of patients with DAVS
showing spontaneous angiographic pattern conversion.
Methods—We assessed clinical and angiographic features of patients with angiographic conversion without any treatment
from a single center database consisting of 335 DAVS cases. Spontaneous angiographic conversion was defined as
complete occlusion of a pre-existing DAVS or conversion of a benign into an aggressive lesion on follow-up diagnostic
subtraction angiography.
Results—One hundred twelve patients were followed without treatment after the initial diagnosis of DAVS. Overall, we
saw pattern conversion on angiography in 18 of the 112 cases (16.1%). Fourteen patients showed spontaneous occlusion
of the shunt (12.5%); the most common locations of spontaneous obliteration were the transverse and cavernous sinuses.
Four patients showed conversion to an aggressive lesion from benign DAVS (4.0%); all of these cases were associated
with occlusion of the ipsilateral draining vein.
Conclusions—DAVS is a dynamic disorder, which will show chronological progression. Spontaneous angiographic
obliteration or conversion into an aggressive type may occur on follow-up of untreated DAVSs. (Stroke. 2010;
41:1489-1494.)
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Dural arteriovenous shunt (DAVS) is a disease in whichabnormal arteriovenous communications develop within
the dura.1 A wide variety of factors have been demonstrated
to be associated with DAVS formation such as sinus throm-
bosis, infections, surgery, postpartum status, and various
coagulopathies all may provide a conducive environment for
disease development.1–4 Angiogenic growth factors also seem
to be associated in the genesis of dural arteriovenous fis-
tula.5,6 Basic fibroblast growth factor and vascular endothelial
growth factors have been shown to be present in the dural
walls of these patients.5
The presence of cortical venous reflux is an important
angiographic feature that is implicated with increased intra-
cranial hemorrhagic rates and a grave outcome with annual
mortality reaching 10%.7–10 Thus, aggressive curative man-
agement is recommended for such lesions. On the other hand,
DAVSs without cortical reflux are considered benign and
conservative management consisting of palliative or observa-
tional treatment is advocated.11,12
Despite the recent growth in the technical management
of this disease, its natural history remains poorly under-
stood. Some isolated case series have hinted that some of
these patients may undergo an angiographic pattern con-
version on long-term follow-up.3,12–22 However, many of
these patients had been treated palliatively and there is still
controversy on whether or how often these lesions may
actually show an evolutive pattern conversion without any
treatment alterations.23,24
The purpose of this study is to define the incidence,
clinical, and angioarchitectural characteristics of patients
with cranial DAVS showing natural temporal pattern
conversions on diagnostic subtraction angiography (DSA)
based on the long-term follow-up data from a large
single-center database.
Materials and Methods
The patients were selected from a single institution database con-
sisting of 335 intracranial DAVSs (Borden Type I, n164; II/III,
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n171) presenting between June 1984 and June 2009.25 The
database has been collected prospectively since 1989 by a team of
both neuroradiologists and neurosurgeons in a multidisciplinary
clinic. The evaluations included a detailed medical history, full
neurological examination, and imaging findings. The diagnosis of
DAVS was based on DSA findings.
The standard management protocol for patients with intracranial
DAVS at the institution throughout the period was observational or
palliative therapy (flow reduction with particles or partial emboliza-
tion) for patients with intolerable symptoms for benign type of
lesions without cortical reflux (Borden Type I); and for aggressive
type lesions with cortical reflux (Borden Type II/III): curative
endovascular or surgical therapy for disconnection of cortical venous
reflux. Manual compression therapy was not implemented on any of
the patients. In general, the patients were followed on an annual basis
in the multidisciplinary clinic. The patients were instructed to return
for an investigation when they noticed any changes of symptoms on
which a DSA or, more recently, a time-resolved MRI with contrast
enhancement and/or time-resolved CT angiography was performed
followed by re-evaluation with DSA.
For this study, a total of 112 patients (Borden Type I, n99;
Borden Type II/III, n13) who were followed without any treatment
were assessed. The reason for observatory follow-up in patients with
aggressive lesions was treatment refusal, technical treatment failure,
or patient death. Among these patients, 34 patients (Borden Type I,
n32; Type II/III, n2) were followed with DSA. These patients
were analyzed for spontaneous angiographic conversion during their
follow-up.
Spontaneous angiographic conversion was defined as complete
occlusion of a pre-existing DAVS or conversion of a Borden Type I
into a Type II/III lesion on follow-up DSA. Patients who had
received any form of palliative, curative endovascular, radiotherapy,
or surgical therapy were excluded. Also, patients who were followed
with only CT angiography or MR angiographic imaging were
excluded.
The diagnostic and follow-up DSA findings were evaluated for
the location, feeders, cortical reflux, major sinus venous outflow
patterns, and outflow restrictions. The database and medical
charts were reviewed for other clinical assessments, including the
age/sex, medical history, and symptomatic changes. Institutional
Review Board approval was obtained with a waiver of informed
consent.
Results
The 112 patients with intracranial DAVS (male:fe-
male41:71; age, mean56.5 years; range: 3 to 89 years)
who were followed without any therapy were located at the
cavernous (n41), transverse (n37), sigmoid (n8), jugu-
lar bulb (n7), foramen magnum (n7, including the hypo-
glossal canal and marginal sinus), and others (n9). Three
cases showed synchronous multiple lesions (superior sagittal
and transverse sinus, tentorium and transverse sinus, and
sigmoid sinus and torcula). Eleven cases were lost to follow-
up. The mean duration of follow-up for these patients was
40.4 months (range, 1 to 187 months).
Overall, angiographically demonstrated pattern conversion
was seen in 18 of the 112 cases (16.1%, mean age, 50.1 years;
male:female10:8). In terms of the patients with DSA
follow-up, 52.9% (18 of 34 patients) showed angiographic
pattern conversion.
Table 1. Summary of Patients Showing Spontaneous Obliteration of DAVS
Case
No.
Sex/Age,
Years
Location/Borden
Type Initial Symptoms
Initial Venous
Features
DSA Interval,
Months
Symptom
Changes DSA Changes
Associated Clinical
Condition
1 M/47 TS, L/I Bruit Intact 76 Resolved TS occlusion
2 M/62 TS, R/I Bruit Intact 140 Resolved* Sinus intact Clival chordoma
operation
3 M/66 CS, R/I Eye swelling, diplopia,
bruit
Slow flow, R IPS/SPS
occlusion
23 Improved Venous phase not
available
4 F/63 CS, bilateral/I Bruit, injection Slow flow, intact
distal veins
112 Fluctuation Venous phase not
available
Anticoagulation
due to DVT
5 M/62 CS, bilateral/I Headache, bruit, visual
loss
Slow flow, L IPS/SOV
occlusion
74 Improved Bilateral CS
obliteration
6 F/41 TS, L/I Pontine hemorrhage; 4
months ago
Slow flow, L TS
stenosis
55 Improved L TS stenosis
7 M/51 HG, R/I Bruit, CN 12 palsy Intact 12 Fluctuation Sinus intact Chemotherapy due
to CLL
8 F/37 TS, L/I Bruit, occipital pain Intact 36 Resolved Sinus intact
9 F/52 JB, L/I Bruit Intact 17 Resolved Sinus intact
10 F/38 HG, R/I Bruit Intact 8 Resolved Sinus intact
11 M/42 CS, R/I Diplopia, bruit,
exophthalmos
Slow flow, R IPS/SPS
occlusion
22 Resolved Venous phase not
available
12 M/43 Parietal convexity,
L/III
Bruit Intact 114 Resolved Sinus intact
13 M/45 SSS/III Parietal hemorrhage Intact 1 Improved Venous phase not
available
14 F/60 TS, L/I Bruit Intact 119 Resolved Venous phase not
available
*Development of ipsilateral symptomatic carotid stenosis.
M indicates male; F, female; TS, transverse sinus; L, left; R, right; CS, cavernous sinus; HG, hypoglossal canal; JB, jugular bulb; SSS, superior sagittal sinus; CN,
cranial nerve; IPS, inferior petrosal sinus; SPS, superior petrosal sinus; SOV, superior ophthalmic vein; DVT, deep vein thrombosis; CLL, chronic lymphocytic leukemia.
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Fourteen patients showed spontaneous occlusion of the
DAVS (12.5%, 14 of 112 patients; mean age, 50.6 years;
male:female8:6; Table 1 ; Figure 1). The mean interval
between diagnosis and spontaneous obliteration on DSA was
56.4 months (range, 1 to 140 months). Two shunts located at
the superior sagittal sinus and the parietal convexity showed
conversion from an aggressive lesion to complete occlusion
(Cases 12 and 13). The rest of the spontaneous occlusions
were initially benign lesions. The most common location of
spontaneous occlusions were the transverse sinus (TS) (n5)
and cavernous sinus (n4). Other locations included the
hypoglossal canal (n1), jugular bulb (n1), clivus (n1),
parietal convexity (n1), and the superior sagittal sinus
(n1). In all cases of cavernous sinus DAVSs, which showed
spontaneous occlusion, the main angioarchitecture of the
shunt consisted of small arterial feeders with slow stagnant
flow. A case of TS DAVS was associated with progressive
occlusion of the shunt and the ipsilateral TS (Case 1). Six
cases maintained sinus patency with spontaneous occlusion
localized to the fistulous compartment. The initial symptoms
had resolved or showed improvement in 12 patients. Two
patients had been re-examined due to recent symptom fluc-
tuations. No case of reopening of a spontaneously occluded
shunt was observed.
Four patients showed conversion of a benign DAVS to an
aggressive lesion (4.0%, 4 of 99 patients; mean age, 48.3
years; male:female2:2; Table 2; Figure 2). Changes in
symptoms such as loss/change of bruit or newly developed
orbital symptoms had prompted the follow-up imaging study
in all 4 patients. The mean interval from diagnosis and
conversion into an aggressive type was 12.3 months (range, 5
to 23 months). These lesions were located at the TS (n1),
cavernous sinus (n1), sigmoid sinus (n1), and hypoglos-
sal canal (n1). All 4 cases were associated with an under-
lying or subsequent development of an occlusion of the
ipsilateral draining sinus or vein. In a case of TS DAVS,
increased flow with dilated feeders in addition to progressive
occlusion of the draining suboccipital vein contributed to
aggressive conversion (Case 15). Transvenous embolization
(Cases 15, 17, 18) or surgical disconnection of the cortical
reflux (Case 16) was performed for these patients.
Discussion
The analysis of our results has shown that intracranial
DAVSs are a dynamic disease that may undergo spontaneous
angiographic pattern conversion. According to a long-term
follow-up of a large single-center database, approximately
16% of the patients showed angiographic pattern conversion
without any treatment.
Various theories have been proposed to explain the angio-
graphic conversions. Awad et al suggested the presence of
several stages in the natural history of DAVS with subsequent
progression from 1 stage to the next.26 Sinus thrombosis,
which is often implicated in the pathogenesis of the disease,
is also frequently associated with its natural evolutive history.
Thrombosis of the recipient sinus or the ultimate fibrosis of
the intraluminal thrombus and the inflamed sinus wall may
cause occlusion of the fistulous communication.3 Concomi-
tant hemorrhage may promote thrombosis of the shunt by
mass effect or vasospasm.15
However, not all spontaneous occlusions have been asso-
ciated with angiographically visible sinus thrombosis.16,27
Luciani et al hypothesized that spontaneous closures may
occur by changes in the structure of the sinus wall. They
proposed that intrinsic compression of the shunts within the
sinus wall caused by focal increase in the sinus size may be
a key mechanism.16 Saito et al suggested that changes in flow
dynamics such as reduction of shunt flow from the external
carotid artery in addition to the venous changes may be an
important factor.27 Despite the angiographic absence of
thrombosis, histological study of DAVS lesions suggests that
Figure 1. Case 7. A 51-year-old man presented with swallowing
difficulty and slurred speech, which began 3 years ago. He also
had pulsatile bruit. The initial lateral view of the right external
carotid artery angiogram showed an arteriovenous shunt on the
medial aspect of the right jugular vein with dilated ascending
pharyngeal artery (A). Drainage was antegrade to the jugular
vein without signs of cortical reflux. Due to the benign nature of
the lesion, the patient was followed by observational manage-
ment. The patient returned approximately 1 year later with a
recent history of sudden worsening of proptosis, headache, and
change of bruit, which spontaneously resolved over a few days.
A repeat angiogram was performed, which showed complete
disappearance of the shunt (B). Spontaneous occlusion of the
shunt was seen. The right jugular vein was intact (not shown).
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microscopic thrombosis is always present and plays a key
role in the release of angiogenic growth factors and the
pathogenesis of DAVSs.5 Our cases show that spontaneous
occlusions may occur with or without angiographically visi-
ble sinus thrombosis. Thrombosis localized to a compartment
or accessory mural channel of the drainage sinus may have
caused shunt occlusions with an angiographically intact main
sinus.28
Sinus thrombosis, which is often associated with shunt
occlusion, could also be the cause of aggressive conversion.18
In our patients with aggressive conversion, all cases showed
occlusion of the venous outflow as the main pathogenic
mechanism of dangerous rerouting. Increase in flow with
extension of the shunt seemed to be an additional aggravating
factor in 1 of our cases (Case 15).
Cavernous DAVSs deserve special mention because these
lesions often manifest the dynamic chronological sequence of
this disease.17,24 Satomi et al has shown that in some cases of
cavernous DAVSs, closure of the posterior drainage routes,
inferior petrosal sinus and pterygoid plexus followed by the
anterior drainage routes, ophthalmic veins, occur in a chro-
nological progression with some progressing to complete
obliteration.17 Suh et al proposed a new classification of the
cavernous DAVS suggesting a chronological progression
from the proliferative type to the restrictive, often with
inferior petrosal sinus obliteration, and a late restrictive type,
pruning of draining veins, with only few arterial feeders and
sluggish retrograde venous flow.24 Progressive venous drain-
age restriction by longstanding elevated venous pressure is a
plausible mechanism for such a disease course.17,24 It is
noteworthy that all the patients with cavernous DAVS in our
series who progressed to spontaneous obliteration showed
similar features as the late restrictive type. Three of these
patients had occlusions of the posterior drainage routes on the
initial DSA and later progressed to complete occlusion.
However, 1 patient who showed progressive occlusion of the
drainage routes transformed into an aggressive type with
rerouting to the cortical veins rather than spontaneous occlu-
sion (Figure 2).
Our experience demonstrates the discrepant natural course
of the DAVS lesion in regard to the location of the lesion,
venous thrombosis, and changes in flow. No specific site was
immune from angiographic conversion. Sinus occlusion was
associated with both shunt obliteration and aggressive con-
version. The underlying venous topography in terms of
location of the shunt and underlying cortical venous connec-
tion may predict the symptoms and the drainage patterns.29
The subsequent development of associated factors such as
venous thrombosis, whether it extends into the shunt nidus
resulting in occlusion or occludes the venous drainage route
and causes dangerous rerouting, or extension/regression of
high flow shunts within the underlying individual venous
topography may ultimately influence the clinical manifesta-
tion and the natural history of the patient.
Although our results show that the incidence of angio-
graphic conversion is not as rare as previously considered,
we do not believe that observational management should
be advocated for patients with aggressive drainage pattern.
The annual morbidity rate is too high and outweighs the
probability of long-term spontaneous occlusion. On the
other hand, benign lesions with slow flow shunts, espe-
cially in the cavernous sinus, were prone to spontaneous
occlusion. Thus, aggressive treatment may be avoided for
such patients.
A change in symptoms should be considered as an indica-
tion for further investigation because it may be a manifesta-
tion of an underlying aggressive conversion. The symptoms
of DAVS are related to the venous drainage pattern of the
shunt.24,30 Changes in symptoms may reflect the angiographic
flow changes of the DAVS. In fact, more than half of the
patients (18 of 34 cases [52.9%]) who were followed with
DSA due mostly to symptomatic changes showed angio-
graphic pattern conversion. Although symptomatic resolution
was often observed with patients showing obliteration of the
shunt, this was not indicative of cure. In 2 cases, the patients
who showed resolution of a previous symptom were associ-
ated with a rerouted aggressive conversion.
Considering the frequency of spontaneous angiographic
conversions, the results of our study call on more vigilance
for clinicians in terms of follow-up of these patients, espe-
cially those showing symptom changes. It also underscores
the importance of a valid noninvasive imaging method for
Table 2. Summary of Patients Showing Aggressive Conversion of DAVS
Case
No.
Sex/Age,
Years
Location/Borden
Type Initial Symptoms
Initial Vein
Features
DSA
Interval,
Months Symptom Changes DSA Changes
Associated Clinical
Condition
15 M/47 TS, L/I Headache, tinnitus L proximal TS
occlusion
5 Transient memory
loss
Flow increase/L
suboccipital
drainage vein
occlusion
16 F/57 CS, L/I Headache, bruit Intact sinus 23 Loss of bruit,
increased diplopia
L IPS/SOV
occlusion
17 F/41 SS, L/I Bruit Intact sinus 11 Loss of bruit L SS, JB
occlusion
L parietal meningioma,
postoperative
18 M/48 HG, L/I Bruit, left Intact sinus 10 Changed bruit pitch,
new L eye swelling
Suboccipital
drainage vein
occlusion
M indicates male; F, female; TS, transverse sinus; L, left; CS, cavernous sinus; SS, sigmoid sinus; HG, hypoglossal canal; IPS, inferior petrosal sinus; SOV, superior
ophthalmic vein; JB, jugular bulb.
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follow-up of the large proportion of these patients who are
followed conservatively.31
The limitation of this study is that a DSA was performed
only in patients who developed symptom changes. Because of
the timespan of our study, we chose DSA as the gold standard
for depiction of angiographic conversions. More recently, it
has become our practice to use time-resolved contrast MRI
and CT angiography in the follow-up of these patients and
any suspicious findings are then investigated with DSA. Once
these noninvasive vascular imaging techniques have proven
to be equal or superior to DSA, then we will obviously rely on
them primarily for guidance of management.
In conclusion, DAVS is a dynamic disease, which will
show chronological progression. Spontaneous angio-
graphic obliteration or conversion into an aggressive type
may occur on follow-up without any treatment. Multiple
factors such as thrombosis, shunt flow, and underlying
venous topography were key factors influencing the angio-
graphic outcome.
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